Fundz

Lumicell reported raising $2.28 Million in an initial SEC Form D filing

PRIVATEMar 08, 2024

Amount Raised

$2.28 Million

$2.28 Million sold, per SEC Form D (first sale Feb 22, 2024)

Round Type

Seed

NewtonBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Lumicell that raised within 45 days of this round, from Fundz verified event records.

  • Astek Diagnostics raised an undisclosed amount (Pre-Series A) on April 7, 2024.
  • NeuroVigil raised $85M (Series B) on April 6, 2024.
  • Beacon Therapeutics raised $120M (Series A) on April 5, 2024.
  • Syntropic Medical raised an undisclosed amount (Funding Round) on April 5, 2024.
  • Varda Space Industries raised $90M (Series B) on April 5, 2024.
  • Glycologix raised $1.5M (Seed) on April 5, 2024.

Who to call at Lumicell, and when

A new round usually means Lumicell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lumicell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lumicell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lumicell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lumicell

Location

275 Washington Street

Newton, Massachusetts, United States

About

Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce healthcare costs. The company’s first product is the Lumicell Direct Visualization System, designed to provide real-time illumination of cancerous tissue within the breast cavity during the initial lumpectomy, potentially reducing repeat surgeries. Lumicell’s proprietary, pan-oncologic optical imaging agent is also being explored across a wide variety of solid tumor indications. The company aims to enhance the standard of care treatment by guiding the resection of additional cancer that may have otherwise been left behind.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lumicell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts15 people are listed at Lumicell. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lumicell's next move

See what Strategic adds

Lumicell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.